Overview

TWYNSTA® (telmisartan/amlodipine) tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents.

Product overview

TWYNSTA® (telmisartan/amlodipine) tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents.

Product key facts

Indication

Treatment of hypertension, it is not recommended to use this combination as initial therapy.

Active ingredients

Telmisartan/amlodipine

Legal category

Prescription only medicine

Concentration

1 tablet contains:

4'-[(1,4'-dimethyl-2'-propyl [2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid (= telmisartan) 80mg

3-Ethyl-5-methyl(4RS)-2-[(2-aminoethoxy)methyl]-4-(2- chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate benzenesulphonate (= amlodipine) 5mg

Administration form

Oral use

Dosage form

Tablet

Pack sizes

TWYNSTA® tablets are available as non-scored, white–off-white/blue, multilayer tablets of oval, biconvex shape containing telmisartan and amlodipine in the strengths described below. TWYNSTA® tablets are debossed with a BOEHRINGER INGELHEIM symbol and an individual product tablet code on one side. TWYNSTA® tablets are supplied for oral administration in the following strengths and package configurations:

Tablets of 80/5 mg. Blister of 2-1000

Reference:

TWYNSTA® approved package insert. Updated in May 2020. Approved in Sep 2020.

TWYNSTA®